Version 1.29 release notes

Release notes

Changes to the NVC have been made since the last release v1.28 (2024-09-26). For your reference, please find a summary of the changes below:

Vaccine lots    •Refer to the 'Vaccine Lots' tab in the Excel workbook to view which specific vaccine lots are new. Column C contains a flag indicating whether a lot is new (marked as 'YES' or 'NO'). You can also find these flags in column J of the 'LotTradenameMapping' tab  

Health Canada QA Lot-to-DIN-mapping •Lot U8207A, U8327A, U8327B, U8467A, U8467B, U8327AA, U8327BA re-mapped from DIN 00514462 to 02528401

Tradenames •33881000087102| COVID-19 COMIRNATY (original strain) tris-sucrose 30 mcg/0.3 mL mRNA PB | (Updated FSN, En & Fr display names ; DIN 02527863 mapping added) •6026100008710 | Chol-O VAXCHORA BN | (Updated market authorization holder mapping) •60601000087107 | Pneu-C-21 CAPVAXIVE Merck | (new) •61241000087101 | Chik IXCHIQ VAL | (new)

Generics •60591000087104 | Pneu-C-21 pneumococcal conjugate 21-valent unspecified | (new) •61231000087107 | RSVAb respiratory syncytial virus monoclonal antibody unspecified | (new)

Antigen / Ig / Antitoxin •60591000087104 | Pneu-C-21 pneumococcal conjugate 21-valent unspecified | (new)

Vaccine Preventable Disease •111864006 | Chikungunya fever | (new)

Summary of changes

• Antigen / Immunoglobulin / Antitoxin: 1
• Vaccine-Preventable Disease: 1
• Generic immunizing agent: 2
• Tradename immunizing agent: 4
• Vaccine lot: 14

Previous version release notes Next version release notes